Expanding Applications: Clinical trials are actively investigating the use of GLP-1 RAs for a wider range of conditions, including addiction, kidney disease, and neurodegenerative disorders, based on their broad physiological effects
Pain 152 , 11921200 (2011)
Risk allele carriers might not only benefit from the latest generations of GLP1R agonists including dual GLP1R/GIPR agonists, but also from recently developed GLP1R PAMs or Gs/cAMP pathway-biased ligands
Lillys pipeline is particularly powerful because it combines high-efficacy injectable innovation with oral scalability
Protein becomes critically important during GLP-1 therapy because rapid weight lossparticularly when exceeding 12 pounds per weekincreases the risk of losing muscle mass alongside fat tissue
1,5 Fiber and resistant starch Fermentable fibers and resistant starches undergo microbial fermentation in the colon, resulting in the production of short-chain fatty acids (SCFAs), including acetate, propionate, and butyrate